FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Dozens of Dem Lawmakers Push to Make Sure Parents Can’t Tell If Kids’ TV Shows Push Transgender Ideology

Illegal Alien Teacher Arrested for Allegedly Aiding Tren de Aragua Mass Shooting

Trump endorsement streak gets unusual boost with South Carolina GOP governor nomination

Trump scores major win as Congress passes housing crackdown on Wall Street investors

Authors of new Trump book reveal his health is the one mystery they couldn’t crack

Ultra-Orthodox Jews become political football for Netanyahu

Former SLED investigator who testified at Alex Murdaugh trial fired from Charleston County Sheriff’s Office

Senators unveil bipartisan bill to safeguard children from AI chatbots

Brooklyn coffee shop that targeted Jewish congressman faces DOJ probe after reported tax, health code issues

Nearby Residents Told to Stay Inside as Semi Carrying Millions of Bees Overturns

Senate Schedule Rearranged as Mitch McConnell Is Set to Miss Another Full Week of Voting

Republicans break with Trump to rebuke Iran war — but it won’t change policy

DHS demands New York sanctuary politicians honor detainer for man convicted of raping corpse on subway

Marjorie Taylor Greene follows Tucker Carlson in ditching the ‘America Last’ Republican Party

Iranian leaders project newfound confidence with international travel spree

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”